WEST PHARMACEUTICAL SVSC ($WST) posted quarterly earnings results on Thursday, July 24th. The company reported earnings of $1.84 per share, beating estimates of $1.52 by $0.32. The company also reported revenue of $766,500,000, beating estimates of $734,722,399 by $31,777,601.
You can see Quiver Quantitative's $WST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WEST PHARMACEUTICAL SVSC Hedge Fund Activity
We have seen 340 institutional investors add shares of WEST PHARMACEUTICAL SVSC stock to their portfolio, and 373 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 2,512,343 shares (-96.9%) from their portfolio in Q1 2025, for an estimated $562,463,350
- DURABLE CAPITAL PARTNERS LP added 935,721 shares (+146.8%) to their portfolio in Q1 2025, for an estimated $209,489,217
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 915,420 shares (-29.4%) from their portfolio in Q1 2025, for an estimated $204,944,229
- VAN ECK ASSOCIATES CORP added 758,355 shares (+110.0%) to their portfolio in Q1 2025, for an estimated $169,780,517
- BROWN ADVISORY INC added 716,442 shares (+28.1%) to their portfolio in Q1 2025, for an estimated $160,397,034
- BLACKROCK, INC. removed 520,601 shares (-7.0%) from their portfolio in Q1 2025, for an estimated $116,552,151
- TWO SIGMA INVESTMENTS, LP added 446,839 shares (+588.0%) to their portfolio in Q1 2025, for an estimated $100,038,315
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WEST PHARMACEUTICAL SVSC Congressional Stock Trading
Members of Congress have traded $WST stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $WST stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ sold up to $15,000 on 02/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
WEST PHARMACEUTICAL SVSC Analyst Ratings
Wall Street analysts have issued reports on $WST in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 03/18/2025
- Keybanc issued a "Overweight" rating on 02/14/2025
To track analyst ratings and price targets for WEST PHARMACEUTICAL SVSC, check out Quiver Quantitative's $WST forecast page.
WEST PHARMACEUTICAL SVSC Price Targets
Multiple analysts have issued price targets for $WST recently. We have seen 3 analysts offer price targets for $WST in the last 6 months, with a median target of $275.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $245.0 on 06/24/2025
- Daniel Markowitz from Evercore ISI Group set a target price of $275.0 on 03/18/2025
- Paul Knight from Keybanc set a target price of $325.0 on 02/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
